Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 13/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6571780 | 0.79 | TYMP (0.49) | TYMPGPR84 | |
| SCHEMBL6571658 | 0.71 | TYMP (0.71) | TYMP | |
| SCHEMBL6570517 | 0.66 | TYMP (0.53) | TYMP | |
| SCHEMBL8709578 | 0.63 | GPR84 (0.49) | TYMPGPR84 | |
| Hydrochloric Acid SCHEMBL11753831 | 0.62 | TYMP (0.49) | TYMPGPR84 | |
| SCHEMBL1690954 | 0.62 | TYMP (1.00) | TYMP | |
| SCHEMBL28448729 | 0.61 | TYMP (0.56) | TYMP | |
| SCHEMBL11003796 | 0.60 | PKM (0.62) | — | |
| SCHEMBL9254063 | 0.60 | GPR84 (0.65) | TYMPGPR84 | |
| SCHEMBL8592127 | 0.59 | G6PD (0.47) | TYMPGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543898-A1 | PYRIMIDINE NUCLEOSIDE TREATMENTS | The Children's Medical Center Corporation (US) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023250015-A1 | PYRIMIDINE NUCLEOSIDE TREATMENTS | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2016142486-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ANTI-ANGIOGENIC RESISTANT CANCER | INSTITUT D'INVESTIGACIÓ BIOMÈDICA DE BELLVITGE (IDIBELL) (ES) | 2016-09-15 | — | — | WO | disclosed |
| EP-3067369-A1 | Methods and compositions for the treatment of anti-angiogenic resistant cancer | Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) (ES) | 2016-09-14 | — | — | EP | disclosed |
| EP-1625234-B1 | BIOSYNTHETIC LABELING AND SEPARATION OF RNA | UNIV LELAND STANFORD JUNIOR (US) | 2009-08-19 | — | — | EP | disclosed |
| EP-1625234-A4 | BIOSYNTHETIC LABELING AND SEPARATION OF RNA | UNIV LELAND STANFORD JUNIOR (US) | 2007-08-22 | — | — | EP | disclosed |
| EP-1625234-A1 | BIOSYNTHETIC LABELING AND SEPARATION OF RNA | The Board of Trustees of The Leland Stanford Junior University (US) | 2006-02-15 | — | — | EP | disclosed |
| US-20040259135-A1 | Biosynthetic labeling and separation of RNA | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-12-23 | — | — | US | disclosed |
| WO-2004101825-A1 | BIOSYNTHETIC LABELING AND SEPARATION OF RNA | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2004-11-25 | — | — | WO | disclosed |